The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies.

Published in: PharmacoEconomics (2022)

This review highlights the substantial economic burden of schizophrenia and a lack of COI studies for LMICs. Recommendations on future research, and good practices on improving the methodological and reporting quality of COI research for schizophrenia are provided.

Keyphrases

bipolar disorder
systematic review
healthcare
primary care
case control
meta analyses
current status
emergency department
randomized controlled trial
clinical practice
quality improvement